Thursday 28 August 2014
 
»
Tag
 
»
Freienbach

FDA approves ‘osteoporosis’ tablet

EffRx Pharmaceuticals has announced that US Food and Drug Administration (FDA) has approved Binosto (alendronate sodium) Effervescent Tablets, previously known as EX101. The tablets are used for the treatment of osteoporosis in postmenopau

More…
 1 2 3 4 5 >  Last ›

calendarCalendar of Events

Ads